Skip to main content
. 2015 Mar 21;29(2):87–92. doi: 10.1007/s40290-015-0090-x
In order to reinvigorate the pharmaceutical drug pipeline, companies need to take better advantage of the available data.
‘Big Data’ relates to large data sets that are highly complex. Data complexity is the key challenge in implementing Big Data approaches.
Integration of disparate data in the pharmaceutical industry will help to identify and validate new drug targets, support early identification of safety and efficacy issues, and improve patient stratification.